Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bioequivalence Study of 3 mg Glimepiride Tablet in Indonesia Healthy Subjects

NCT05468879 is registered in ClinicalTrials.gov with PT Harsen Laboratories as lead sponsor.

NCT NCT05468879
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05468879 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bioequivalence Study of 3 mg Glimepiride Tablet in Indonesia Healthy Subjects
Lead sponsor
PT Harsen Laboratories
Phase
Not applicable
Overall status
Completed
Start date
September 21, 2020
Completion date
January 6, 2021
Enrollment
34 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug use